Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FromBio is a South Korean biotechnology and health functional food company specializing in the development of natural-source ingredients and therapeutic solutions. The company is well-known for its market-leading health supplements, such as Boswellia for joint health and Mastic Gum for gastrointestinal health. Beyond its commercial food business, FromBio is aggressively expanding into the biopharmaceutical sector, focusing on stem cell-based therapies for hair loss and chronic diseases. It operates its own R&D center and manufacturing facilities to maintain a vertically integrated business model from raw material sourcing to final product distribution. The company is listed on the KOSDAQ exchange and continues to invest in proprietary drug delivery systems and cell differentiation technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FromBio.